Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Hematology-Oncology Associates of CNY has appointed Jennifer Pichoske as chief executive officer effective February 15, 2025.

Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...

MidAmerica Cancer Care (MACC), a trusted name in Kansas City and western Missouri cancer care, is proud to announce it has ...

Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...

In a report released today, Roger Song from Jefferies maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target of ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

Co., Inc. (NYSE:MRK), a global healthcare leader, faces a complex landscape of opportunities and challenges as it navigates the competitive biopharmaceutical industry. This comprehensive analysis ...

The cost of cancer may be higher than previously estimated, according to a recent report from the American Cancer Society.

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...